Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 54: 930-932, 2008; 10.1373/clinchem.2007.102160
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mikesh, L. M.
Right arrow Articles by Bruns, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mikesh, L. M.
Right arrow Articles by Bruns, D. E.
(Clinical Chemistry. 2008;54:930-932.)
© 2008 American Association for Clinical Chemistry, Inc.


Letters to the Editor

Stabilization of Glucose in Blood Specimens: Mechanism of Delay in Fluoride Inhibition of Glycolysis

Leann M. Mikesh and David E. Brunsa

Department of Pathology, University of Virginia, Charlottesville, VA

aAddress correspondence to this author at: Department of Pathology, P O Box 800168, University of Virginia School of Medicine, Charlottesville, VA 22908, email dbruns@virginia.edu

The first 20% of the full text of this article appears below.


To the Editor:

The recent report by Gambino(1) brought attention to the often overlooked fact that fluoride does not prevent loss of plasma glucose during the first 30–90 min (or longer) after blood collection(2). Although fluoride is effective in preventing later loss of glucose(1)(2), the mechanism of the delay in its action is a matter of some interest.

Fluoride acts primarily by inhibiting enolase in the glycolytic pathway. Fluoride strongly inhibits the enzyme in the presence of inorganic phosphate. The inhibitory species is the fluorophosphate ion, which when bound to magnesium forms a complex with enolase and inactivates the enzyme. The delay in fluoride’s prevention of glucose loss in blood samples is sometimes attributed to a postulated delay in the entry of fluoride ion into the blood cells in which the glycolytic enzymes reside. Several observations cast doubt on this explanation, however.

As part of a project for quality improvement of sample-handling requirements, we collected blood from a volunteer into four . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.